Kentaro Yoshimatsu
Founder at Rin Institute, Inc.
Network origin in Kentaro Yoshimatsu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 57 | |
Anaeropharma Science, Inc.
 Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan.
5
| Holding Company | Biotechnology | 5 |
Rin Institute, Inc.
 Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site."
4
| Holding Company | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kentaro Yoshimatsu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Chief Executive Officer Chairman Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
Sunplanet Co., Ltd.
 Sunplanet Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Eisai Co., Ltd., Sunplanet Co., Ltd. is a Japanese company that provides facility management, pharmaceutical analysis, and research development services. The company is based in Tokyo, Japan and was founded in 2001. | Miscellaneous Commercial Services | President Director/Board Member President Director/Board Member | |
| University of Tokyo | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Executive Officer | |
| University of Hitotsubashi | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Eisai Manufacturing Ltd.
 Eisai Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Manufacturing Ltd. is a pharmaceutical company based in Hatfield, UK. The British company's focus is on developing new medicines for neglected tropical diseases and malaria, improving access to medicines for non-communicable diseases, and promoting sustainability. Eisai Manufacturing is committed to funding the 3rd phase of health innovative technology fund activities. The company's official corporate website provides information on their initiatives and HHC concept. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
EA Pharma Co., Ltd.
 EA Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., EA Pharma Co., Ltd. is a specialty pharmaceutical company based in Tokyo, Japan. The Japanese company specializes in digestive diseases such as inflammatory intestinal diseases and focuses on advanced research and development and marketing activities to solve unmet medical needs. EA Pharma Co. provides drug discovery research, development research related to gastrointestinal diseases, and drug discovery base technology research to meet the further medical needs of patients. The company's production department aims to create products that have effective and safety as a drug and ensure the quality of the product. EA Pharma Co. aims to be the largest digestive pharmacy in Japan, which was born in the integration of the digestive business of the Eisai group and the Ajinomoto group's digestive business. | Pharmaceuticals: Major | Director/Board Member President | |
Eisai R&D Management Co., Ltd.
 Eisai R&D Management Co., Ltd. BiotechnologyHealth Technology Part of Eisai Co., Ltd., Eisai R&D Management Co., Ltd. engages in research and development of pharmaceuticals. The company is based in Bunkyo, Japan. | Biotechnology | President President | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| Keio University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Tokyo University of Science | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Eisai Ltd. (United Kingdom)
 Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Ltd. is a British company that develops pharmaceutical products. The company is based in Hatfield, UK. The company was founded in 1988. Gary Bryan Hendler has been the CEO of the company since 2008. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| GLOBIS University | College/University | Masters Business Admin | |
SCOHIA PHARMA, Inc.
 SCOHIA PHARMA, Inc. Miscellaneous Commercial ServicesCommercial Services SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe. | Miscellaneous Commercial Services | Director/Board Member | |
Quantum Biosystems, Inc.
 Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Biotechnology | Director/Board Member | |
Sonire Therapeutics, Inc. (TY)
 Sonire Therapeutics, Inc. (TY) Medical SpecialtiesHealth Technology Sonire Therapeutics, Inc. (TY) is a company based in Tokyo, Japan. The Japanese company specializes in developing a next-generation ultrasonic guide ultrasonic ultrasonic treatment device using acoustic engineering (ultrasonic) technology created from academia, which conducts cutting-edge research. The device uses high-intensity focused ultrasound (HIFU) and is designed to be used under ultrasonic guidance. The company was founded in 2020 and the CEO is Toru Sato. | Medical Specialties | Director/Board Member | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree | |
Fast Track Initiative, Inc.
 Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative, Inc. (FTI) is a Venture Capital firm, a subsidiary of Life Science Management, Inc. founded in 2004 by Koichi Ashida and Hiromichi Kimura. Fast Track Initiative, Inc. is headquartered in Tokyo with additional office in the Unites States. | Investment Managers | Private Equity Analyst | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Megakaryon Corp.
 Megakaryon Corp. Medical/Nursing ServicesHealth Services Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan. | Medical/Nursing Services | Director/Board Member | |
UTokyo Innovation Platform Co.,Ltd.
 UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | Investment Managers | Private Equity Investor | |
| Veranova LP | Corporate Officer/Principal | ||
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Brandeis University | College/University | Doctorate Degree | |
| University of Barcelona | College/University | Doctorate Degree | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Lycoming College | College/University | Undergraduate Degree | |
| Drexel University College of Medicine | College/University | Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin | |
Nextpoint Therapeutics, Inc.
 Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chief Executive Officer | |
Japanese Chamber of Commerce & Industry of New York, Inc.
 Japanese Chamber of Commerce & Industry of New York, Inc. Miscellaneous Commercial ServicesCommercial Services Japanese Chamber of Commerce Industry of New York, Inc. is non-profit organization that engages in facilitation of trade between the U.S. and Japan. The company was founded on November 14, 1932 by 14 prominent Japanese businessman, and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
| Fujisawa Pharmaceutical Co | Corporate Officer/Principal | ||
| University of Massachusetts | College/University | Graduate Degree | |
Argo 21 Corp.
 Argo 21 Corp. Information Technology ServicesTechnology Services Argo 21 Corp. provides software maintenance and development services. It also provides engineering and consulting services. The company was founded in April 1984 and is headquartered in Tokyo, Japan. | Information Technology Services | President | |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| PENTAIR PLC | Industrial Machinery | Comptroller/Controller/Auditor | |
| Quinnipiac University | College/University | Undergraduate Degree | |
| IPSEN | Pharmaceuticals: Major | Human Resources Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
| ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Duke University School of Medicine | College/University | Doctorate Degree | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
StandexMeder Electronics GmbH
 StandexMeder Electronics GmbH Electrical ProductsProducer Manufacturing Part of Standex International Corp., StandexMeder Electronics GmbH designs, manufactures and markets reed switches, relays, sensors and other products. The company is based in Singen, Germany. The CEOs of the German company are John Meeks, Ademir Sarcevic, Rainer Hombeck. | Electrical Products | Chief Executive Officer | |
| University of Bridgeport | College/University | Undergraduate Degree | |
| Thunderbird School of Global Management | College/University | Graduate Degree |
Statistics
International
| United States | 28 |
| Japan | 16 |
| United Kingdom | 4 |
| Spain | 3 |
| France | 3 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 18 |
| Commercial Services | 6 |
| Finance | 3 |
| Producer Manufacturing | 3 |
Operational
| Director/Board Member | 89 |
| Corporate Officer/Principal | 71 |
| Independent Dir/Board Member | 22 |
| Chief Executive Officer | 14 |
| President | 12 |
Most connected contacts
- Stock Market
- Insiders
- Kentaro Yoshimatsu
- Company connections
